Dr Stavros Nicolaou is the Aspen Pharmacare Group's Senior Executive responsible for Strategic Trade Development. Previously he was CEO of Aspen's Export Business. He was instrumental in introducing the first generic ARV's on the African continent developed by Aspen, which have gone on to save hundreds of thousands of lives.
Dr Nicolaou has over 30 years' experience in the South African and international pharmaceutical industry and is a previous winner of the SA Institute of Marketing Management (IMM) Health Care Marketer of the Year Award. He was a previous recipient Monte Rubenstein Award for Proficiency in Pharmaceutics from the Wits University Pharmacy Faculty. He was awarded the Order of the Lion of St Mark by the Greek Orthodox Pope and Patriarch, Theodoros II. He has been inducted as a Fellow of the Pharmaceutical Society of South Africa (PSSA), one of the highest honours bestowed by the PSSA, and was recently awarded an Honorary Doctorate of Science in Medicine from Wits University.
He has previously and continues to serve on a number of industry & associated structures, some of which include member of Business for South Africa (B4SA) Steering Committee and Chairperson of the B4SA Health Workgroup, Chairman of the Public Health Enhancement Fund (PHEF) , a joint collaboration between the private health sector and the Minister of Health, appointed to the National Covid 19 Vaccine Co-ordinating Committee (NCVCC) and the Covid-19 Vaccine Joint Oversight Steering Committee,
